Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 20,706 KARD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Kardigan, Inc. (KARD) | Grant/Award | 20,706 | n/a |
| Jun 8, 2026 | 10x Genomics, Inc. (TXG) | Grant/Award | 8,829 | n/a |
| Jun 2, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,799 | n/a |
| Apr 3, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/Award | 6,808 | n/a |
| Mar 23, 2026 | EXACT SCIENCES CORP (EXAS) | Disposition to Issuer | 6,725 | n/a |
| Aug 1, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 45,748 | $473.9K |
| Jun 16, 2025 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 9,994 | n/a |
| Jun 5, 2025 | 10x Genomics, Inc. (TXG) | Grant/Award | 15,357 | n/a |
| Jun 5, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 3,173 | n/a |
| Jan 6, 2025 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 6,387 | n/a |